# A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

> **NCT00046176** · PHASE3 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 240 (—)

## Conditions studied

- Infection, Human Immunodeficiency Virus I
- HIV Infection

## Interventions

- **DRUG:** abacavir/lamivudine
- **DRUG:** abacavir
- **DRUG:** lamivudine

## Key facts

- **NCT ID:** NCT00046176
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08-26
- **Primary completion:** 2004-05-17
- **Final completion:** 2004-05-17
- **Target enrollment:** 240 (—)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046176, "A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00046176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*